CDKN1A and neoplasm: Additionally, Awatef Allouch et al. demonstrated that CDKN1A enhances the prognosis of T-ALL patients by increasing the phagocytic ability of tumor-associated macrophages through transcriptional inhibition of signal-regulatory protein α (SIRPα) [36].